ANF A and F delivers 2 percent Q1 2026 EPS beat shares fall 239 percent on muted investor sentiment Johnson Johnson JNJ Secures FDA Priority Review for IMAAVY Targeting FirstofItsKind Indication for Warm Autoimmune Hemolytic Anemia Federal Reserve Headquarters Renovation Dispute and Governance Analysis